Evotec
Evotec is a global biotechnology company headquartered in Hamburg, Germany, specializing in drug discovery and preclinical development.
No open positions right now. Check back soon!
Browse all jobsAbout the company
Evotec is a global biotechnology company headquartered in Hamburg, Germany, specializing in drug discovery and preclinical development. The company integrates breakthrough science with AI-driven innovation and advanced technologies to accelerate the journey from concept to cure, with expertise spanning small molecules, biologics, cell therapies, and associated modalities. Evotec's platform includes proprietary technologies such as Molecular Patient Databases, PanOmics, and iPSC-based disease modeling, and it serves all Top 20 pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. With a global team of more than 4,800 experts operating from sites across Europe and the U.S., Evotec focuses on therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology.
Evotec's Spain presence is not explicitly detailed in the provided evidence, but the company operates internationally with a strong European footprint. The work culture emphasizes scientific excellence, operational agility, and flexible partnering models, offering roles that range from scientific research to business analysis and finance. For international professionals, Evotec provides opportunities to work on cutting-edge drug discovery projects, collaborate with leading pharmaceutical companies, and contribute to a data-driven R&D approach that aims to deliver better treatments to patients sooner.
For International Professionals
- Evotec is headquartered in Hamburg, Germany, and operates multiple sites across Europe and the U.S., offering potential relocation opportunities within its global network.
- The company works with all Top 20 pharma companies and over 800 biotechs, providing exposure to a wide range of drug discovery and development projects.
- Evotec's platform includes advanced technologies such as AI-driven innovation, Molecular Patient Databases, and iPSC-based disease modeling, offering opportunities to work with cutting-edge science.
- The company has a global team of more than 4,800 experts, indicating a large and diverse international workforce.
- Evotec focuses on key therapeutic areas including oncology, cardiovascular and metabolic diseases, neurology, and immunology, which may appeal to professionals with expertise in these fields.
Company History
Evotec was founded in 1993 in Hamburg, Germany, as a drug discovery company. Over the years, it has grown into a global life science company with a multimodality platform covering small molecules, biologics, and cell therapies, and has established partnerships with all Top 20 pharma companies and over 800 biotechs. The company has expanded through acquisitions and organic growth, including the creation of Just - Evotec Biologics and the integration of Cyprotex for ADME-Tox solutions.